Vaxcyte Inc. Common Stock vs Sotera Health Company Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while Sotera Health Company Common Stock trades at $17.68 (market cap $5.20B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 2× Sotera Health Company Common Stock's market cap, and Vaxcyte Inc. Common Stock is more actively traded (2,644,694 versus 1,647,777). Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Sotera Health Company Common Stock for 0 Days on average.
| PCVX | SHC | |
|---|---|---|
Market Cap | $10.51B | $5.20B |
Volume | 2,644,694 | 1,647,777 |
Sector | Health | Health |
52-Week High | $73.82 | $19.57 |
52-Week Low | $40.32 | $13.13 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $7.11B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.
Read more on SHC →